A randomized phase II study of Cisplatin plus S-1 versus Cisplatin plus Pemetrexed, with thoracic radiotherapy for locally advanced non-squamous non-small cell lung cancer
Latest Information Update: 04 Dec 2020
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Pemetrexed
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SPECTRA
- 01 Dec 2020 Status changed from active, no longer recruiting to completed.
- 10 Sep 2019 Results of 2-year survival data presented at the 20th World Conference on Lung Cancer
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress